BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2013
View Archived Issues
ImmBio obtains funding to develop multistrain pneumococcal vaccine
Read More
Novel potent maturation inhibitors developed by DFH Pharma
Read More
Promising antitumor activity seen for NOV-C-ter in vitro and in vivo
Read More
MSCT response criteria compared in patients with GIST
Read More
Activartis gives update on its anticancer immune therapy for glioma
Read More
S100-P as a novel biomarker in patients with gallbladder carcinoma
Read More
TFF3 as a biomarker for the prognosis and recurrence of EAC
Read More
Astellas files for Japanese approval of ipragliflozin
Read More
Kyoto University and Shionogi establish collaboration
Read More
MDCT enterography shows promise for diagnosing gastrointestinal tuberculosis
Read More
Researchers present data for inclacumab from the SELECT-ACS trial
Read More
Scientists at Takeda Pharmaceutical patent new histamine H3 receptor antagonists
Read More
Novartis synthesizes new BACE inhibitors
Read More
Novel potassium channel blockers presented by Merck & Co.
Read More
Boehringer Ingelheim discloses new phosphodiesterase PDE4B inhibitors
Read More
Researchers at Roche prepare new protein kinase inhibitors for cancer
Read More
Ceregene and ADCS complete enrollment in CERE-110 study
Read More
Isis Pharmaceuticals reports phase I data for ISIS-CRPRx
Read More
Merck & Co. and Luminex to develop companion diagnostic for MK-8931
Read More
N30 Pharmaceuticals treats first patient in phase Ib/IIa trial of N-6022
Read More
Scripps Research Institute and Takeda Pharmaceuticals expand research collaboration
Read More
French regulatory authorities approve phase I/II trial of BL-8020
Read More
FDA clears Quidel's assay for RSV and human MPV
Read More
Miraculins enters license agreement regarding biomarker for pregnancy risk
Read More
FDA approves Navidea's imaging drug Lymphoseek
Read More